Global Cord Blood Corporation (NYSE: CO) announced June 4, 2019, that its board of directors received a non-binding proposal letter from Cordlife Group Limited for the two companies to combine by way of a statutory merger. Under the terms of the nonbinding proposal, Cordlife will issue its ordinary shares at SGD0.5 per ordinary share, and in exchange, will receive all of the outstanding ordinary shares of Global Cord Blood Corporation (GCBC) at US$7.50 per share. [Read more…]
Cord Blood Banking – Present and Future Outlook
Cord blood banking is defined as the collection and storage of stem cells present within the umbilical cord blood of a newborn for future medical use. Umbilical cord blood is rich in a type of stem cell known as a hematopoietic stem cell (HSC). A large market for the storage of these cells has come into existence over the past 30 years, with public and private cord blood banks now present in all major healthcare markets worldwide. [Read more…]
Cord Blood Banking Market Consolidation
After a rapid growth period through the mid-2000s, the global cord blood banking market reached saturation and stabilized through approximately 2012. Since that time, the market has been aggressively consolidating.
In this article:
When Did Cord Blood Banking Start? Landmark Events in Cord Blood & Tissue
The global cord blood industry came into existence in the early 1990’s with the formation of several leading cord blood banks in the USA, followed by the establishment of cord blood banks across the globe. However, the history of cord blood stem cell transplantation begins much earlier than that.
The History of Banking Cord Blood
In this article:
- Umbilical Cord Stem Cells
- Cord Blood Stem Cells Transplant
- Public Cord Blood Banking
- Private Cord Blood Banking
- Cord Blood Registry
- Cord Blood Banking Companies in Asia
- Banking Umbilical Cord Tissue
- Placental Blood and Tissue Banking
- Menstrual Fluid Stem Cells
- Saving Cord Blood and Tissue
- Diversity in Stem Cell Banking
- Cord Blood Expansion Technologies
How the Cord Blood and Tissue Market is Changing
The global cord blood and tissue banking market is consolidating, driven by the emergence of holding companies and aggressive M&A activity. This is creating risks for cord blood market participants, as well as new opportunities.
Serious threats to the industry include:
- Low rates of stored cord blood utilization
- Utilization of bone marrow and peripheral blood stem cells as alternative sources of stem cells for HSCT
- Growing prevalence of haploidentical transplantation
- Expensive transplant procedures, ranging from $200-300K
- Difficulty educating Obstetricians about the future value of cellular therapies
- Low rates of market penetration
- Low rates of cord blood awareness among expectant parents
